Trials / Withdrawn
WithdrawnNCT04664621
HepQuant to Predict Hepatic Encephalopathy After TIPS
HepQuant to Predict Hepatic Encephalopathy in Patients Who Receive Transjugular Intrahepatic Portosystemic Shunt (TIPS) for Refractory Ascites - a Pilot Study
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Northwestern University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A pilot study to determine if a simple blood test can predict patients at risk for significant episodes of confusion and disorientation that can occur in patients who receive an artificial shunt through the liver to control complications of liver disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | HepQuant | Patients undergoing TIPS procedure will receive a HepQuant test prior to and then after TIPS. |
Timeline
- Start date
- 2020-02-25
- Primary completion
- 2021-09-30
- Completion
- 2021-09-30
- First posted
- 2020-12-11
- Last updated
- 2022-08-09
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04664621. Inclusion in this directory is not an endorsement.